I identified 59 randomised managed trials out-of calcium consumption you to definitely said BMD since the an outcome

Baseline services

7 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 Fifteen studied dietary sources of calcium (n=810 calcium, n=723 controls),16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 and 51 studied calcium supplements (n=6547 calcium, n=5710 controls).7 12 13 14 15 17 19 20 21 22 26 28 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 Table 1 ? shows study design and selected baseline characteristics for included studies of dietary calcium. Tables 2 and 3 show the study design and selected baseline characteristics for trials of calcium supplements, without and with additional vitamin D, respectively. ? ? Further details are in tables A-C in appendix 2. Of the 15 randomised controlled trials of dietary sources of calcium, 10 used milk or milk powder, two used dairy products, and three used hydroxyapatite preparations. Of the 51 trials of calcium supplements, 36 studied calcium monotherapy, 13 co-administered CaD, and two were multi-arm studies of both. Table 4 summarises other features of the trials ? . Most of them studied calcium without vitamin D in women aged <70 living in the community; the mean baseline dietary calcium intake was <800 mg/day; and most trials lasted ?2 years. A calcium dose of >500 mg/day was used in most trials, but a higher proportion of trials of calcium supplements used a dose of ?1000 mg/day. Table C in appendix 2 shows our assessment of risk of bias. Of the 15 trials of dietary sources of calcium, we assessed two as low risk of bias, six shagle přihlásit as moderate risk, and seven as high risk. Of the 51 trials of calcium supplements, we assessed 19 as low risk of bias, 12 as moderate risk, and 20 as high risk.

Type of randomised regulated trials and you may selected baseline qualities from eligible examples of calcium which also put nutritional D medicine

First analyses

Table 5 ? summarises the outcome of your meta-analyses. Expanding calcium supplements intake of dietary source increased BMD by the 0.6-1.0% during the full stylish and you may total human anatomy at 1 year and you will of the 0.7-step one.8% within the internet sites additionally the lumbar lower back and you will femoral neck at the a couple of years (figs step one and you will 2 ? ? . There is zero impact on BMD from the forearm.

Fig step one Haphazard consequences meta-studies out of effectation of fat reduction types of calcium supplements on commission alter in bones mineral occurrence (BMD) out-of baseline at the 1 year

Fig dos Random consequences meta-research away from aftereffect of fat loss sourced elements of calcium supplements towards fee alter for the limbs mineral occurrence (BMD) out-of standard on 24 months

When we restricted the analyses to your 12 randomised regulated examples away from dairy otherwise dairy products, by leaving out about three samples away from hydroxyapatite, discover nothing improvement in the outcome. Calcium supplements improved BMD anyway five skeletal websites by 0.7-1.4% at 12 months (figs step three and cuatro ? ? ), because of the 0.8-step one.5% on couple of years (figs 5 and you can six ? ? ), and also by 0.8-step 1.8% on more two and a half age (fig 7 ? ) (range of time of products are 3 to 5 many years).